154 related articles for article (PubMed ID: 34980961)
1. Treatment of Axillary Bromhidrosis with Topical 2% Glycopyrronium Bromide Cream: A Prospective, Non-randomized, Open-label Study.
Gregoriou S; Markantoni V; Campanati A; Martina E; Offidani A; Kouris A; Platsidaki E; Bokotas H; Stratigos A; Rigopoulos D; Kontochristopoulos G
J Clin Aesthet Dermatol; 2021 Nov; 14(11):E61-E63. PubMed ID: 34980961
[TBL] [Abstract][Full Text] [Related]
2. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok RD; Quiring J; Drew J; Pariser DM
Am J Clin Dermatol; 2019 Aug; 20(4):593-604. PubMed ID: 31111409
[TBL] [Abstract][Full Text] [Related]
3. A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.
Abels C; Soeberdt M; Kilic A; Reich H; Knie U; Jourdan C; Schramm K; Heimstaedt-Muskett S; Masur C; Szeimies RM
Br J Dermatol; 2021 Aug; 185(2):315-322. PubMed ID: 33445205
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial.
Szeimies RM; Abels C; Kilic A; Reich H; Berger B; Schulze Zur Wiesche E; Schramm K; Litzka L; Heimstaedt-Muskett S; Masur C
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):823-830. PubMed ID: 36606529
[TBL] [Abstract][Full Text] [Related]
5. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.
Pariser DM; Hebert AA; Drew J; Quiring J; Gopalan R; Glaser DA
Am J Clin Dermatol; 2019 Feb; 20(1):135-145. PubMed ID: 30378087
[TBL] [Abstract][Full Text] [Related]
6. A case series evaluating microwave-based therapy for axillary hyperhidrosis and bromhidrosis.
Mohamoud AA; Zeraiq L; Vestergaard T
J Dermatolog Treat; 2022 May; 33(3):1572-1575. PubMed ID: 33622150
[TBL] [Abstract][Full Text] [Related]
7. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
Hebert AA; Glaser DA; Green L; Werschler WP; Forsha DW; Drew J; Gopalan R; Pariser DM
Pediatr Dermatol; 2019 Jan; 36(1):89-99. PubMed ID: 30451318
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.
Hebert AA; Glaser DA; Green L; Hull C; Cather J; Drew J; Gopalan R; Pariser DM
Pediatr Dermatol; 2020 May; 37(3):490-497. PubMed ID: 32147881
[TBL] [Abstract][Full Text] [Related]
9. Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double-blind, vehicle-controlled study.
Yokozeki H; Fujimoto T; Wanatabe S; Ogawa S; Fujii C
J Dermatol; 2022 Jan; 49(1):86-94. PubMed ID: 34636057
[TBL] [Abstract][Full Text] [Related]
10. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
Pariser DM; Lain EL; Mamelok RD; Drew J; Mould DR
Clin Pharmacokinet; 2021 May; 60(5):665-676. PubMed ID: 33433785
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of iontophoresis with glycopyrronium bromide for treatment of primary palmar hyperhidrosis.
Chia HY; Tan AS; Chong WS; Tey HL
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1167-70. PubMed ID: 21812834
[TBL] [Abstract][Full Text] [Related]
12. Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use.
Lamb YN
Clin Drug Investig; 2019 Nov; 39(11):1141-1147. PubMed ID: 31571127
[TBL] [Abstract][Full Text] [Related]
13. Treatment of bromhidrosis with a glycine-soja sterocomplex topical product.
Gregoriou S; Rigopoulos D; Chiolou Z; Papafragkaki D; Makris M; Kontochristopoulos G
J Cosmet Dermatol; 2011 Mar; 10(1):74-7. PubMed ID: 21332920
[TBL] [Abstract][Full Text] [Related]
14. A Prospective, Long-Term Follow-Up Study of 1,444 nm Nd:YAG Laser: A New Modality for Treating Axillary Bromhidrosis.
Jung SK; Jang HW; Kim HJ; Lee SG; Lee KG; Kim SY; Yi SM; Kim JH; Kim IH
Ann Dermatol; 2014 Apr; 26(2):184-8. PubMed ID: 24882972
[TBL] [Abstract][Full Text] [Related]
15. Reversibility of hyperhidrosis post axillary depilatory laser.
Helou J; Habre M; Soutou B; Maatouk I; Ibrahim T; Tomb R
Lasers Med Sci; 2014 Mar; 29(2):717-21. PubMed ID: 23887660
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis.
Bloudek LM; Gillard KK; Nguyen VB; Klein SZ
J Med Econ; 2021; 24(1):29-37. PubMed ID: 33256494
[TBL] [Abstract][Full Text] [Related]
17. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.
Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok R; Drew J; Quiring J; Pariser DM
J Am Acad Dermatol; 2019 Jan; 80(1):128-138.e2. PubMed ID: 30003988
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.
Müller C; Berensmeier A; Hamm H; Dirschka T; Reich K; Fischer T; Rzany B
J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1278-84. PubMed ID: 23004926
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Safety and Efficacy of Botulinum Toxin A Treatment in Adolescent Patients with Axillary Bromhidrosis.
Wang T; Dong J; He J
Aesthetic Plast Surg; 2018 Apr; 42(2):560-564. PubMed ID: 29344685
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive 1,444-nm Nd:YAG laser treatment for axillary bromhidrosis.
Piccolo D; Mutlag MH; Pieri L; Fusco I; Conforti C; Crisman G; Bonan P
Front Med (Lausanne); 2023; 10():1034122. PubMed ID: 36814776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
